LivaNova (NASDAQ:LIVN) Issues FY24 Earnings Guidance

LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $2.95-3.05 for the period, compared to the consensus EPS estimate of $2.99. LivaNova also updated its FY 2024 guidance to 2.950-3.050 EPS. Analyst Upgrades and Downgrades Several analysts recently commented on the company. Mizuho upgraded LivaNova […]

Related Keywords

,Voloridge Investment Management ,Pricet Rowe Associates Inc ,Barclays Plc ,Nuveen Asset Management ,Needham Company ,Livanova Company Profile ,Get Free Report ,Moderate Buy ,Investment Management ,Asset Management ,Advanced Circulatory ,Livanova Daily ,Livanova ,Nasdaq Livn ,Livn ,Medical ,Guidance ,Earnings ,Preannouncement ,